The store will not work correctly when cookies are disabled.
5-bromocytisine
ID: ALA1084012
Cas Number: 207390-16-7
PubChem CID: 15519736
Max Phase: Preclinical
Molecular Formula: C11H13BrN2O
Molecular Weight: 269.14
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: 5-Bromocytisine | 5-bromocytisine|CHEMBL1084012|DTXSID101126759|BDBM50482167|207390-16-7|(1R,5S)-11-Bromo-1,2,3,4,5,6-hexahydro-1,5-methano-8H-pyrido[1,2-a][1,5]diazocin-8-one
Canonical SMILES: O=c1ccc(Br)c2n1C[C@@H]1CNC[C@H]2C1
Standard InChI: InChI=1S/C11H13BrN2O/c12-9-1-2-10(15)14-6-7-3-8(11(9)14)5-13-4-7/h1-2,7-8,13H,3-6H2/t7-,8+/m0/s1
Standard InChI Key: QGUJDQNVLMZXLT-JGVFFNPUSA-N
Molfile:
RDKit 2D
17 19 0 0 0 0 0 0 0 0999 V2000
-2.2849 -12.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2849 -13.2146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5701 -13.6265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8553 -13.2146 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8553 -12.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5701 -11.9748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5701 -14.4543 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1363 -13.6265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5597 -11.5702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5785 -12.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2745 -12.8099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5701 -11.1468 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1.2729 -11.9849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1363 -11.9748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7197 -11.3914 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
0.5785 -13.2146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5785 -14.0396 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 2 0
4 8 1 0
8 16 1 0
5 14 1 0
14 9 1 0
16 10 1 0
14 10 1 0
16 11 1 0
6 12 1 0
9 13 1 0
11 13 1 0
14 15 1 6
16 17 1 6
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.14 | Molecular Weight (Monoisotopic): 268.0211 | AlogP: 1.32 | #Rotatable Bonds: ┄ |
Polar Surface Area: 34.03 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.82 | CX LogP: 0.39 | CX LogD: -1.97 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.77 | Np Likeness Score: -0.25 |
References
1. Abin-Carriquiry JA, Zunini MP, Cassels BK, Wonnacott S, Dajas F.. (2010) In silico characterization of cytisinoids docked into an acetylcholine binding protein., 20 (12): [PMID:20493692] [10.1016/j.bmcl.2010.04.092] |